Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. PS Ratio 2013–2026
Current and historical P/S ratio for Enanta Pharmaceuticals Inc. (ENTA): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 5.30.
From: 09/30/2025To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Enanta Pharmaceuticals Inc. PS Ratio — FAQ
Enanta Pharmaceuticals Inc. (ENTA) ps ratio over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's ps ratio history?
The chart and table above show Enanta Pharmaceuticals Inc.'s ps ratio by year and by quarter, including the growth rate.